Tag: expanded access program

  • FDA Expanded Access Programs

    —

    by

    Alicia
    in , ,

    History and Background Expanded Access Programs (EAP) are governed by 21 CFR 312, Subpart I and are also referred to as “compassionate use.” They are designed to allow use of investigational drugs outside a clinical trial for subjects who do not meet the requirements of active running trial(s). There are 3 types of EAP: individual…